meloxidyl

The application concerns MELOXIDYL, a generic medicinal product as defined in Article 13(2)(b) of
Directive 2001/82/EC, as amended by Directive 2004/28/EC. The reference veterinary medicinal
product is Metacam 1.5 mg/ml oral suspension for dogs, a product with a Community Marketing
Authorisation and originally authorised in Germany in 1992.
The active substance is Meloxicam, a non-steroidal anti-inflammatory drug belonging to the acidic
enolcarboxamide (oxicam) class. In vitro, Meloxicam is preferentially active against
cyclooxygenase-2. The recommended posology consists of an initial single dose of 0.2 mg
Meloxicam/kg body weight on the first day, followed by once daily administration (24-hour intervals)
of 0.1 mg Meloxicam/kg body weight. The product is to be administered mixed with food.